I just bought this pharma stock for its next generation of blockbuster drugs — and its dividend

Post date: 2026-10-28 07:03:02
Views: 57
AbbVie is entering a new chapter of growth, fueled by its blockbuster immunology drugs and expanding neuroscience business. Investor Kevin Simpson shares why he's optimistic.
Please click Here to read the full story.
 
Other Top and Latest Questions:
Using miles to fly for Thanksgiving? These are the most expensive and cheapest routes
Trump offers UFC chief Dana White press secretary job
Here are the 2 big things we're watching in the stock market in the week ahead
In pictures: France protests draw 146,000 as clashes erupt for fourth straight weekend
Teach me more about drugs (lots of drugs)
Dead-End Job: Limited Series: Full First Season
Movie: Godzilla Minus Zero
Book: Inventing The Renaissance
The Great British Bake Off: Free From Party Week
The Gilded Age: Ring the Bells